ID: ALA361209

Max Phase: Preclinical

Molecular Formula: C18H13N5O2

Molecular Weight: 331.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1nc(C#CCOc2ccccc2)cn2nc(-c3ccco3)nc12

Standard InChI:  InChI=1S/C18H13N5O2/c19-16-18-21-17(15-9-5-11-25-15)22-23(18)12-13(20-16)6-4-10-24-14-7-2-1-3-8-14/h1-3,5,7-9,11-12H,10H2,(H2,19,20)

Standard InChI Key:  BDSUXOVMTRRHAO-UHFFFAOYSA-N

Associated Targets(non-human)

Adenosine A2a receptor 3360 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine A1 receptor 6163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Adenosine receptors; A1 & A2a 368 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 331.34Molecular Weight (Monoisotopic): 331.1069AlogP: 2.40#Rotatable Bonds: 3
Polar Surface Area: 91.47Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.61CX LogD: 3.61
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.58Np Likeness Score: -1.46

References

1. Yao G, Haque S, Sha L, Kumaravel G, Wang J, Engber TM, Whalley ET, Conlon PR, Chang H, Kiesman WF, Petter RC..  (2005)  Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists.,  15  (3): [PMID:15664803] [10.1016/j.bmcl.2004.11.062]

Source